Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid

被引:264
作者
Schmidt, E [1 ]
Obe, K [1 ]
Bröcker, EB [1 ]
Zillikens, D [1 ]
机构
[1] Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany
关键词
D O I
10.1001/archderm.136.2.174
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To investigate the possible correlation of levels of circulating anti-BP180 autoantibodies with disease activity in bullous pemphigoid (BP). Design: Diagnostic study. Setting: Regional referral center at a university dermatology department. Patients: Fifteen patients with typical clinical, histologic, and immunofluorescence findings of BP who had not received prior systemic treatment. Interventions: Initially, 6 consecutive patients with BP were treated with oral doxycycline and niacinamide. Subsequently, 9 consecutive patients with BP received a combination of oral dapsone and prednisolone. Main Outcome Measures: Disease activity, serum levels of autoantibodies to BP180, and liters of antibasement membrane zone autoantibodies were assayed before initiation of treatment and 4 and 8 weeks later. Reactivity to BP180 was analyzed by enzyme-linked immunosorbent assay using a recombinant form of BP180 NC16A. Titers of anti-basement membrane zone auto antibodies were assayed by indirect immunofluorescence on 1-mol/L sodium chloride-split human skin. Results: In both treatment groups, disease actitity correlated with serum levels of autoantibodies to BP180 NC16A (P = .004 [dapsone-prednisolone] and .007 [doxycycline-niacinamide]). No correlation was seen between disease activity and indirect immunofluorescence reactivity (P = .18 and .16, respectively). In patients receiving dapsone plus prednisolone, the dose of corticosteroids necessary to suppress new blister formation correlated with anti-BP180 reactivity (P = .002). Conclusions: In contrast to indirect immunofluorescence reactivity that reflects reactivity to both BP180 and BP230, serum levels of autoantibodies to BP180 correlate with disease activity in BP. Assaying reactivity to BP180 should be a helpful guide for the therapeutic management of patients with this disease. Our results underline the pathogenic relevance of autoantibodies to human BP180.
引用
收藏
页码:174 / 178
页数:5
相关论文
共 33 条
[1]   BULLOUS PEMPHIGOID - CLINICAL AND IMMUNOLOGICAL FOLLOW-UP AFTER SUCCESSFUL THERAPY [J].
AHMED, AR ;
MAIZE, JC ;
PROVOST, TT .
ARCHIVES OF DERMATOLOGY, 1977, 113 (08) :1043-1046
[2]  
Ameglio F, 1998, BRIT J DERMATOL, V138, P611
[3]   Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida [J].
Bedane, C ;
McMillan, JR ;
Balding, SD ;
Bernard, P ;
Prost, C ;
Bonnetblanc, JM ;
Diaz, LA ;
Eady, RAJ ;
Giudice, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (06) :901-907
[4]  
BURGER DR, 1976, J IMMUNOL, V117, P797
[5]   The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy [J].
DAuria, L ;
Fei, PC ;
Pietravalle, M ;
Ferraro, C ;
Mastroianni, A ;
Bonifati, C ;
Giacalone, B ;
Ameglio, F .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (01) :59-64
[6]  
Delaporte E, 1996, J IMMUNOL, V157, P3642
[7]   AN INVITRO MODEL OF IMMUNE COMPLEX-MEDIATED BASEMENT-MEMBRANE ZONE SEPARATION CAUSED BY PEMPHIGOID ANTIBODIES, LEUKOCYTES, AND COMPLEMENT [J].
GAMMON, WR ;
MERRITT, CC ;
LEWIS, DM ;
SAMS, WM ;
CARLO, JR ;
WHEELER, CE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (04) :285-290
[8]  
Ghohestani RF, 1996, EUR J DERMATOL, V6, P491
[9]  
GIUDICE GJ, 1993, J IMMUNOL, V151, P5742
[10]   CLONING AND PRIMARY STRUCTURAL-ANALYSIS OF THE BULLOUS PEMPHIGOID AUTOANTIGEN BP180 [J].
GIUDICE, GJ ;
EMERY, DJ ;
DIAZ, LA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (03) :243-250